Rocket Pharmaceuticals, Inc. (RCKT) Financial Statements (2024 and earlier)

Company Profile

Business Address 350 FIFTH AVENUE
NEW YORK, NY 10118
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:356,394,000388,700,000482,700,000304,100,000213,132,000100,014,000
Cash and cash equivalents140,517,000232,694,000297,098,000185,383,000111,355,00078,720,000
Short-term investments215,877,000156,046,000185,621,000118,732,00094,375,00021,294,000
Other undisclosed cash, cash equivalents, and short-term investments (40,000)(19,000)(15,000)7,402,000 
Other undisclosed current assets7,666,0003,359,0004,645,0003,654,000(4,044,000)1,033,000
Total current assets:364,060,000392,059,000487,345,000307,754,000209,088,000101,047,000
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization46,664,00048,480,00050,521,000 
Operating lease, right-of-use asset1,972,0001,569,000914,0002,051,000
Property, plant and equipment29,009,00022,299,00019,206,00029,295,0002,027,000563,000
Long-term investments and receivables 43,276,000   7,402,000 
Long-term investments 43,276,000   7,402,000 
Intangible assets, net (including goodwill)64,878,00030,815,00030,815,00030,815,00030,815,000 
Goodwill39,154,00030,815,00030,815,00030,815,00030,815,000 
Intangible assets, net (excluding goodwill)25,724,000     
Deposits noncurrent assets608,000455,000455,000455,000545,000 
Restricted cash and investments1,340,0001,343,0001,568,0001,525,0001,436,000 
Other noncurrent assets      168,000
Other undisclosed noncurrent assets    226,000  
Total noncurrent assets:187,747,000104,961,000103,479,00064,367,00042,225,000731,000
TOTAL ASSETS:551,807,000497,020,000590,824,000372,121,000251,313,000101,778,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:36,660,00019,615,00025,472,00017,352,00015,372,0004,070,000
Interest and dividends payable 1,122,0001,241,0001,241,0001,246,000
Employee-related liabilities4,533,0004,875,0002,588,0001,904,000 
Accounts payable2,095,000725,0001,456,0004,424,000 451,000
Accrued liabilities13,715,0001,678,0002,167,000893,0001,279,0002,373,000
Other undisclosed accounts payable and accrued liabilities20,850,00012,679,00015,852,0008,206,00010,948,000 
Debt1,736,0001,689,0006,519,000957,000  
Other undisclosed current liabilities773,000863,000626,000   
Total current liabilities:39,169,00022,167,00032,617,00018,309,00015,372,0004,070,000
Noncurrent Liabilities
Long-term debt and lease obligation19,269,00020,049,00054,552,00046,492,00041,447,000 
Long-term debt, excluding current maturities   35,066,00045,049,00041,447,000 
Finance lease, liability19,269,00019,144,00018,988,000 
Liabilities, other than long-term debt3,683,00080,000136,00023,000457,000403,000
Deferred rent credit     457,000
Other liabilities2,595,00080,000136,00023,000 403,000
Operating lease, liability1,088,000905,000498,0001,443,000
Other undisclosed noncurrent liabilities      49,541,000
Total noncurrent liabilities:22,952,00020,129,00054,688,00046,515,00041,904,00049,944,000
Total liabilities:62,121,00042,296,00087,305,00064,824,00057,276,00054,014,000
Equity
Equity, attributable to parent489,686,000454,724,000503,519,000307,297,000194,037,00047,764,000
Common stock791,000645,000610,000548,000452,00068,000
Treasury stock, value (47,000)  (53,000)(668,000) 
Additional paid in capital1,203,074,000946,152,000825,794,000489,925,000300,253,000316,086,000
Accumulated other comprehensive income (loss)(357,000)(161,000)(42,000)20,000(127,000)(16,000)
Accumulated deficit(713,775,000)(491,912,000)(322,843,000)(183,143,000)(105,873,000)(268,374,000)
Total equity:489,686,000454,724,000503,519,000307,297,000194,037,00047,764,000
TOTAL LIABILITIES AND EQUITY:551,807,000497,020,000590,824,000372,121,000251,313,000101,778,000

Income Statement (P&L) (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Gross profit:(3,900,000)(1,200,000)    
Operating expenses(224,343,000)(167,248,000)(134,303,000)(76,151,000)(71,156,000)(26,737,000)
Other undisclosed operating income3,900,0001,200,000    
Operating loss:(224,343,000)(167,248,000)(134,303,000)(76,151,000)(71,156,000)(26,737,000)
Nonoperating income
(Investment Income, Nonoperating)
      819,000
Interest and debt expense(1,862,000)(2,977,000)(6,967,000)(5,958,000)(6,039,000)(3,579,000)
Loss from continuing operations:(226,205,000)(170,225,000)(141,270,000)(82,109,000)(77,195,000)(29,497,000)
Loss before gain (loss) on sale of properties:(170,225,000)(141,270,000)(82,109,000)(77,195,000)(29,497,000)
Net loss:(226,205,000)(170,225,000)(141,270,000)(82,109,000)(77,195,000)(29,497,000)
Other undisclosed net income attributable to parent4,342,0001,156,0001,570,0004,839,0002,677,000 
Net loss available to common stockholders, diluted:(221,863,000)(169,069,000)(139,700,000)(77,270,000)(74,518,000)(29,497,000)

Comprehensive Income (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(226,205,000)(170,225,000)(141,270,000)(82,109,000)(77,195,000)(29,497,000)
Other undisclosed comprehensive income      38,000
Comprehensive loss:(226,205,000)(170,225,000)(141,270,000)(82,109,000)(77,195,000)(29,459,000)
Other undisclosed comprehensive income, net of tax, attributable to parent4,146,0001,037,0001,508,0004,986,0002,550,000 
Comprehensive loss, net of tax, attributable to parent:(222,059,000)(169,188,000)(139,762,000)(77,123,000)(74,645,000)(29,459,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: